Suki Secures USD 70 Million to Expand AI Healthcare Solutions

Suki Secures USD 70 Million to Expand AI Healthcare Solutions
Suki, an Artificial Intelligence (AI) technology company that provides AI voice solutions for healthcare, has raised USD 70 million in a Series D round, bringing its total funding to USD 165 million. The latest round, led by Hedosophia with substantial additional investment from Venrock and other existing investors, including March Capital, Flare Capital, Breyer Capital, and inHealth Ventures, will drive product development, commercial initiatives, and leadership expansion.

  • Make Telecom Talk My Trusted Source
  • Source of Google
  • Source of Google

Also Read: Affineon Health Launches AI Platform to Streamline Healthcare Admin Tasks

Product Development with New Investment

Suki plans to use the new investment to accelerate product development and expand beyond its current offerings. Its AI-powered solutions include Suki Assistant, an AI assistant that streamlines administrative tasks for clinicians, and the Suki Platform, a suite of developer tools for technology partners building AI experiences in their solutions.

Suki Assistant: Streamlining Clinical Workflows

Suki claims its Assistant helps clinicians save time on tedious administrative tasks by generating notes ambiently, taking dictation and commands, simplifying coding, and answering clinical questions by retrieving relevant chart data from the EHR (electronic health record).

“Suki has been growing at an exponential rate, with over a dozen major health systems and hospitals deploying or expanding access to Suki in the last two months alone,” the company said.

“We are in a new phase of growth. The healthcare industry is clamoring for AI and we are proud to offer a suite of full-featured solutions that seamlessly interoperate with existing tools,” said Punit Soni, CEO and founder of Suki.

“With the support of our investors, we’ll accelerate our growth, diversify Suki’s capabilities, and deepen relationships with strategic partners such as MedStar Health, one of the most important collaborators in Suki’s history. MedStar Health was fundamental in helping us build essential capabilities including our bidirectional and seemingly ‘invisible’ EHR integration, which is why we have the highest clinician adoption rates in the industry. Together, we have demonstrated how a technology company and health system can meaningfully innovate together and advance physician well-being and patient care.”